1,621 research outputs found
IL-15 promotes human myogenesis and mitigates the detrimental effects of TNFα on myotube development
Studies in murine cell lines and in mouse models suggest that IL-15 promotes myogenesis and may protect against the inflammation-mediated skeletal muscle atrophy which occurs in sarcopenia and cachexia. The effects of IL-15 on human skeletal muscle growth and development remain largely uncharacterised. Myogenic cultures were isolated from the skeletal muscle of young and elderly subjects. Myoblasts were differentiated for 8 d, with or without the addition of recombinant cytokines (rIL-15, rTNFα) and an IL-15 receptor neutralising antibody. Although myotubes were 19% thinner in cultures derived from elderly subjects, rIL-15 increased the thickness of myotubes (MTT) from both age groups to a similar extent. Neutralisation of the high-affinity IL-15 receptor binding subunit, IL-15rα in elderly myotubes confirmed that autocrine concentrations of IL-15 also support myogenesis. Co-incubation of differentiating myoblasts with rIL-15 and rTNFα, limited the reduction in MTT and nuclear fusion index (NFI) associated with rTNFα stimulation alone. IL-15rα neutralisation and rTNFα decreased MTT and NFI further. This, coupled with our observation that myotubes secrete IL-15 in response to TNFα stimulation supports the notion that IL-15 serves to mitigate inflammatory skeletal muscle loss. IL-15 may be an effective therapeutic target for the attenuation of inflammation-mediated skeletal muscle atrophy
Metabolomics in the Analysis of Inflammatory Diseases
Most infections and traumatic injuries are cleared or repaired relatively rapidly and metabolic homoeostasis is soon restored. However, there is a broad range of inflammatory
diseases which involve chronic activation of the immune system and, as a result, chronic
persistent inflammation. We have been studying the metabolic consequences of chronic
inflammatory diseases with the aim of identifying metabolic fingerprints which may
provide clues about why the localised tissue disease persists
The serum proteome of Atlantic salmon, Salmo salar, during pancreas disease (PD) following infection with salmonid alphavirus subtype 3 (SAV3)
Salmonid alphavirus is the aetological agent of pancreas disease (PD) in marine Atlantic salmon, Salmo salar, and rainbow trout, Oncorhynchus mykiss, with most outbreaks in Norway caused by SAV subtype 3 (SAV3). This atypical alphavirus is transmitted horizontally causing a significant economic impact on the aquaculture industry. This histopathological and proteomic study, using an established cohabitational experimental model, investigated the correlation between tissue damage during PD and a number of serum proteins associated with these pathologies in Atlantic salmon. The proteins were identified by two-dimensional electrophoresis, trypsin digest and peptide MS/MS fingerprinting. A number of humoral components of immunity which may act as biomarkers of the disease were also identified. For example, creatine kinase, enolase and malate dehydrogenase serum concentrations were shown to correlate with pathology during PD. In contrast, hemopexin, transferrin, and apolipoprotein, amongst others, altered during later stages of the disease and did not correlate with tissue pathologies. This approach has given new insight into not only PD but also fish disease as a whole, by characterisation of the protein response to infection, through pathological processes to tissue recovery.
Biological significance:
Salmonid alphavirus causes pancreas disease (PD) in Atlantic salmon, Salmo salar, and has a major economic impact on the aquaculture industry. A proteomic investigation of the change to the serum proteome during PD has been made with an established experimental model of the disease. Serum proteins were identified by two-dimensional electrophoresis, trypsin digest and peptide MS/MS fingerprinting with 72 protein spots being shown to alter significantly over the 12 week period of the infection. The concentrations of certain proteins in serum such as creatine kinase, enolase and malate dehydrogenase were shown to correlate with tissue pathology while other proteins such as hemopexin, transferrin, and apolipoprotein, altered in concentration during later stages of the disease and did not correlate with tissue pathologies. The protein response to infection may be used to monitor disease progression and enhance understanding of the pathology of PD
G55.0+0.3: A Highly Evolved Supernova Remnant
Multi-frequency analysis has revealed the presence of a new supernova
remnant, G55.0+0.3, in the Galactic plane. A kinematic distance of 14 kpc has
been measured from HI spectral line data. The faint, clumpy half-shell is
non-thermal and has a physical radius of 70 pc. Using an evolutionary model,
the age of the remnant is estimated to be on the order of one million years,
which exceeds conventional limits by a factor of five. The remnant may be
associated with the nearby pulsar J1932+2020, which has a spin-down age of 1.1
million years. This work implies that the radiative lifetimes of remnants could
be much longer than previously suggested.Comment: 27 pages, 7 figures in 9 files (figures 1 and 2 require 2 files
each), Accepted for publication in The Astrophysical Journal (Jan. 20, 1998
volume
On Zurek's derivation of the Born rule
Recently, W. H. Zurek presented a novel derivation of the Born rule based on
a mechanism termed environment-assisted invariance, or "envariance" [W. H.
Zurek, Phys. Rev. Lett. 90(2), 120404 (2003)]. We review this approach and
identify fundamental assumptions that have implicitly entered into it,
emphasizing issues that any such derivation is likely to face.Comment: 8 pages; v2: minor clarifications added; v3: reference to Zurek's
quant-ph/0405161 added. To appear in Foundations of Physics (Cushing Volume
- …